Compare Moderna, Inc. (MRNA) vs AT&T Inc. (T) Price & Performance

Moderna, Inc.Trade

AT&T Inc.Trade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs AT&T Inc. — how do they compare? Moderna, Inc. trades at $60.83 (market cap $23.88B), while AT&T Inc. trades at $24.4 (market cap $164.80B). The key difference: AT&T Inc. is far larger — about 6.9× Moderna, Inc.'s market cap, and AT&T Inc. pays a 4.62% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.

	MRNA	T
Market Cap	$23.88B	$164.80B
Sector	Health	Media
52-Week High	$81.80	$29.62
52-Week Low	$22.36	$20.49
Enterprise Value	$20.03B	$310.12B
Dividend Yield	—	4.62%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

New report analyzes 1,350+ precision medicine deals from 2019-2026, revealing market trends and deal structures.Researchandmarkets.Com · 4 days agoNeutral Global influenza vaccine market to grow to $13.32B by 2030, driven by aging population and vaccine innovationsResearchandmarkets.Com · 4 days agoNeutral View details →

AT&T boosts fiber subscribers and free cash flow amid transformation and 4.8% dividend yield.Seeking Alpha · 1 day agoBullish Verizon cellphone service outage affects thousands in major US cities Saturday afternoonCNBC · 3 days agoBearish View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About AT&T Inc.

AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.